Who makes Norwalk VLP vaccine?

Norwalk VLP vaccine is developed by Takeda.

What development phase is Norwalk VLP vaccine in?

Norwalk VLP vaccine is in Phase 1.

What are the side effects of Norwalk VLP vaccine?

Common side effects include Nasopharyngitis, Blood glucose increased, Arthralgia, Oropharyngeal pain, Upper respiratory tract infection, Pain in extremity.

Last reviewed 2026-04-20 · How we verify

Norwalk VLP vaccine

Takeda · Phase 1 active Biologic Quality 10/100

At a glance

Generic name	Norwalk VLP vaccine
Sponsor	Takeda
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

Nasopharyngitis
Blood glucose increased
Arthralgia
Oropharyngeal pain
Upper respiratory tract infection
Pain in extremity

Key clinical trials

Norovirus Bivalent-Vaccine Efficacy Study (PHASE1, PHASE2)
Norwalk Vaccine Study (PHASE1, PHASE2)
Phase 1 Norwalk Vaccine Study (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Norwalk VLP vaccine CI brief — competitive landscape report
Norwalk VLP vaccine updates RSS · CI watch RSS
Takeda portfolio CI